EnligHTN: Results and Update on Clinical Trial Status - V. Papademetriou, MD, DSc

↳ This is a section part of Moment: CRT 2015 Technology & Innovation - Renal Denervation: Review of the Data and Lessons from the Studies

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

EnligHTN: Results and Update on Clinical Trial Status presented by V. Papademetriou, MD, DSc at CRT 2015

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$10.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: Renal Denervation: Review of the Data and Lessons from the Studies

Track: Technology & Innovation

Learning Objectives

  • Updates in Renal Denervation

Other Components in this Moment

Overview
Durability of the SYMPLICITY HTN-1 and HTN-2 Studies - Stephan C. Bertog, MD
SYMPLICITY 3 Subgroups and Analysis In-Depth - David E. Kandzari, MD
EnligHTN: Results and Update on Clinical Trial Status - V. Papademetriou, MD, DSc
Insights from the Global SYMPLICITY Registry - Felix Mahfoud, MD
Lessons from the Vessix Studies - Martin B. Leon, MD
Review of the Clinical Outcome of Non-RF Technologies: Ultrasound, Local Drug Delivery, and Brachytherapy - Horst Sievert, MD
Loading Simple Education